Nitric oxide and pulmonary arterial pressures in pulmonary hypertension

Roberto Machado, Medha Vini Londhe Nerkar, Raed A. Dweik, Jeffrey Hammel, Allison Janocha, Jacqueline Pyle, Daniel Laskowski, Constance Jennings, Alejandro C. Arroliga, Serpil C. Erzurum

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Decreased production of vasodilator substances such as nitric oxide (NO) has been proposed as important in development of pulmonary arterial hypertension (PAH). We hypothesize that NO measured over time serves as a non invasive marker of severity of PAH and response to therapy. We prospectively and serially measured exhaled NO and carbon monoxide (CO), a vasodilator and anti-inflammatory product of heme oxygenases, in 17 PAH patients in conjunction with hemodynamic parameters over 2 years. Although pulmonary artery pressures and NO were similar in all patients at entry to the study, NO increased in the 12 individuals who survived to complete the study, and correlated with change in pulmonary artery pressures. In contrast, CO did not change or correlate with hemodynamic parameters. Investigation of NO-oxidant reaction products in PAH in comparison to controls suggests that NO synthesis is impaired in the lung and that reactive oxygen species may be involved in the pathophysiology of pulmonary hypertension. Endogenous NO is inversely related to pulmonary artery pressure in PAH, with successful therapy of PAH associated with increase in NO.

Original languageEnglish (US)
Pages (from-to)1010-1017
Number of pages8
JournalFree Radical Biology and Medicine
Volume37
Issue number7
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Fingerprint

Pulmonary Hypertension
Arterial Pressure
Nitric Oxide
Lung
Pulmonary Artery
Hemodynamics
Carbon Monoxide
Vasodilator Agents
Pressure
Heme Oxygenase (Decyclizing)
Reaction products
Oxidants
Reactive Oxygen Species
Anti-Inflammatory Agents
Therapeutics

Keywords

  • Carbon monoxide
  • Free radicals
  • Nitric oxide
  • Pulmonary hypertension
  • Reactive oxygen species
  • Vasodilation

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Machado, R., Londhe Nerkar, M. V., Dweik, R. A., Hammel, J., Janocha, A., Pyle, J., ... Erzurum, S. C. (2004). Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radical Biology and Medicine, 37(7), 1010-1017. https://doi.org/10.1016/j.freeradbiomed.2004.06.039

Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. / Machado, Roberto; Londhe Nerkar, Medha Vini; Dweik, Raed A.; Hammel, Jeffrey; Janocha, Allison; Pyle, Jacqueline; Laskowski, Daniel; Jennings, Constance; Arroliga, Alejandro C.; Erzurum, Serpil C.

In: Free Radical Biology and Medicine, Vol. 37, No. 7, 01.10.2004, p. 1010-1017.

Research output: Contribution to journalArticle

Machado, R, Londhe Nerkar, MV, Dweik, RA, Hammel, J, Janocha, A, Pyle, J, Laskowski, D, Jennings, C, Arroliga, AC & Erzurum, SC 2004, 'Nitric oxide and pulmonary arterial pressures in pulmonary hypertension', Free Radical Biology and Medicine, vol. 37, no. 7, pp. 1010-1017. https://doi.org/10.1016/j.freeradbiomed.2004.06.039
Machado, Roberto ; Londhe Nerkar, Medha Vini ; Dweik, Raed A. ; Hammel, Jeffrey ; Janocha, Allison ; Pyle, Jacqueline ; Laskowski, Daniel ; Jennings, Constance ; Arroliga, Alejandro C. ; Erzurum, Serpil C. / Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. In: Free Radical Biology and Medicine. 2004 ; Vol. 37, No. 7. pp. 1010-1017.
@article{3c60ca1e196e46f39f71a8018a7b355f,
title = "Nitric oxide and pulmonary arterial pressures in pulmonary hypertension",
abstract = "Decreased production of vasodilator substances such as nitric oxide (NO) has been proposed as important in development of pulmonary arterial hypertension (PAH). We hypothesize that NO measured over time serves as a non invasive marker of severity of PAH and response to therapy. We prospectively and serially measured exhaled NO and carbon monoxide (CO), a vasodilator and anti-inflammatory product of heme oxygenases, in 17 PAH patients in conjunction with hemodynamic parameters over 2 years. Although pulmonary artery pressures and NO were similar in all patients at entry to the study, NO increased in the 12 individuals who survived to complete the study, and correlated with change in pulmonary artery pressures. In contrast, CO did not change or correlate with hemodynamic parameters. Investigation of NO-oxidant reaction products in PAH in comparison to controls suggests that NO synthesis is impaired in the lung and that reactive oxygen species may be involved in the pathophysiology of pulmonary hypertension. Endogenous NO is inversely related to pulmonary artery pressure in PAH, with successful therapy of PAH associated with increase in NO.",
keywords = "Carbon monoxide, Free radicals, Nitric oxide, Pulmonary hypertension, Reactive oxygen species, Vasodilation",
author = "Roberto Machado and {Londhe Nerkar}, {Medha Vini} and Dweik, {Raed A.} and Jeffrey Hammel and Allison Janocha and Jacqueline Pyle and Daniel Laskowski and Constance Jennings and Arroliga, {Alejandro C.} and Erzurum, {Serpil C.}",
year = "2004",
month = "10",
day = "1",
doi = "10.1016/j.freeradbiomed.2004.06.039",
language = "English (US)",
volume = "37",
pages = "1010--1017",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Nitric oxide and pulmonary arterial pressures in pulmonary hypertension

AU - Machado, Roberto

AU - Londhe Nerkar, Medha Vini

AU - Dweik, Raed A.

AU - Hammel, Jeffrey

AU - Janocha, Allison

AU - Pyle, Jacqueline

AU - Laskowski, Daniel

AU - Jennings, Constance

AU - Arroliga, Alejandro C.

AU - Erzurum, Serpil C.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Decreased production of vasodilator substances such as nitric oxide (NO) has been proposed as important in development of pulmonary arterial hypertension (PAH). We hypothesize that NO measured over time serves as a non invasive marker of severity of PAH and response to therapy. We prospectively and serially measured exhaled NO and carbon monoxide (CO), a vasodilator and anti-inflammatory product of heme oxygenases, in 17 PAH patients in conjunction with hemodynamic parameters over 2 years. Although pulmonary artery pressures and NO were similar in all patients at entry to the study, NO increased in the 12 individuals who survived to complete the study, and correlated with change in pulmonary artery pressures. In contrast, CO did not change or correlate with hemodynamic parameters. Investigation of NO-oxidant reaction products in PAH in comparison to controls suggests that NO synthesis is impaired in the lung and that reactive oxygen species may be involved in the pathophysiology of pulmonary hypertension. Endogenous NO is inversely related to pulmonary artery pressure in PAH, with successful therapy of PAH associated with increase in NO.

AB - Decreased production of vasodilator substances such as nitric oxide (NO) has been proposed as important in development of pulmonary arterial hypertension (PAH). We hypothesize that NO measured over time serves as a non invasive marker of severity of PAH and response to therapy. We prospectively and serially measured exhaled NO and carbon monoxide (CO), a vasodilator and anti-inflammatory product of heme oxygenases, in 17 PAH patients in conjunction with hemodynamic parameters over 2 years. Although pulmonary artery pressures and NO were similar in all patients at entry to the study, NO increased in the 12 individuals who survived to complete the study, and correlated with change in pulmonary artery pressures. In contrast, CO did not change or correlate with hemodynamic parameters. Investigation of NO-oxidant reaction products in PAH in comparison to controls suggests that NO synthesis is impaired in the lung and that reactive oxygen species may be involved in the pathophysiology of pulmonary hypertension. Endogenous NO is inversely related to pulmonary artery pressure in PAH, with successful therapy of PAH associated with increase in NO.

KW - Carbon monoxide

KW - Free radicals

KW - Nitric oxide

KW - Pulmonary hypertension

KW - Reactive oxygen species

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=4444354032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444354032&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2004.06.039

DO - 10.1016/j.freeradbiomed.2004.06.039

M3 - Article

C2 - 15336317

AN - SCOPUS:4444354032

VL - 37

SP - 1010

EP - 1017

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 7

ER -